aid: amberstone-biosciences

name: Amberstone Biosciences

description: 'Amberstone Biosciences Inc. discovers transformative immunotherapeutics, focusing on tumor‑activated T‑MATE™ technology to develop precise, safe cancer treatments. The company pioneers next‑gen immunotherapies that trigger immune responses only in tumors, minimizing harm to healthy tissue. Their pipeline spans innovative antibody‑drug conjugates and novel biologics aimed at solid tumors, leveraging proprietary platforms to unlock therapeutic potential previously deemed undruggable.'

url: https://raw.githubusercontent.com/api-evangelist/amberstone-biosciences/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-09-24 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-09-24'

modified: '2026-09-24'

tags:
- Company
- Biotechnology
- Immunotherapy
- Cancer
- Therapeutics

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/amberstone-biosciences-hosts.yml
- type: DomainSecurity
  url: security/amberstone-biosciences-domain-security.yml
- type: Website
  url: http://amberstonebio.com/
- type: About
  url: http://amberstonebio.com/web/about.php
- type: Contact
  url: http://amberstonebio.com/web/contact.php
- type: Documentation
  url: http://amberstonebio.com/web/science.php

apis: []
x-coverage:
  state: unreadable
  reason: js-rendered-docs
  detail: The provider's documentation pages are HTML with no machine‑readable API specifications.
  evidence:
    - url: https://amberstonebio.com/web/science.php
      status: 200
  checked: 2026-09-24
x-enrichment:
  date: '2026-09-24'
  status: enriched
  artifacts_added: 5
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local